title: Navigating the uncharted waters of combination therapy in pulmonary arterial hypertension: COMPASS or dead-reckoning.
authors.affiliation: Pulmonary Vascular Diseases Clinic, Dept of Cardiology, Cliniques Universitaires de Bruxelles - Hôpital Erasme, Brussels, Belgium jeanluc.vachiery@erasme.ulb.ac.be.
authors.forename: Jean-Luc
authors.initials: JL
authors.lastname: Vachiery
authors.affiliation: Division of Pulmonary and Critical Care Medicine, University of California San Diego School of Medicine, La Jolla, CA, USA.
authors.forename: Lewis J
authors.initials: LJ
authors.lastname: Rubin
mesh_terms: D000959:Antihypertensive Agents / Q000008:administration & dosage*; D000077300:Bosentan; D065627:Familial Primary Pulmonary Hypertension / Q000150:complications*; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy*; D008297:Male; D000068677:Sildenafil Citrate / Q000008:administration & dosage*; D013449:Sulfonamides / Q000008:administration & dosage*; D014665:Vasodilator Agents / Q000008:administration & dosage*
chemical_list: D000959:Antihypertensive Agents; D013449:Sulfonamides; D014665:Vasodilator Agents; D000068677:Sildenafil Citrate; D000077300:Bosentan